The Curious Cases of Paraparesis - Case 1
Hello! I'm Sakshi Chittimaneni (Roll No.145), a 4th year medical student.
I've been given these three cases' data here :
https://medicinedepartment.blogspot.com/2020/05/case-based-online-learning-assignment.html?m=1
to solve in an attempt to understand the topic of paraparesis.
CASE 1 :
The details to the patient's entire clinical history, examination findings and investigations can be found here
https://hitesh116.blogspot.com/2020/05/12may-2020-elog-medicine-intern.html?m=1
"AN 18-YEAR-OLD MALE WITH WEAKNESS OF BOTH LOWER LIMBS SINCE 20 DAYS"
After having read and comprehended the data, I have created a problem list in order of the patient's perceived priority following which I have discussed the root causes of these problems :
Other significant findings on examination are:
Higher mental functions, Sensory system and Cranial nerve functions are normal.
Motor system:
Palpation-
Inherited Myopathies and Muscular Dystrophies:
I've been given these three cases' data here :
https://medicinedepartment.blogspot.com/2020/05/case-based-online-learning-assignment.html?m=1
to solve in an attempt to understand the topic of paraparesis.
CASE 1 :
The details to the patient's entire clinical history, examination findings and investigations can be found here
https://hitesh116.blogspot.com/2020/05/12may-2020-elog-medicine-intern.html?m=1
"AN 18-YEAR-OLD MALE WITH WEAKNESS OF BOTH LOWER LIMBS SINCE 20 DAYS"
After having read and comprehended the data, I have created a problem list in order of the patient's perceived priority following which I have discussed the root causes of these problems :
- Progressive weakness in both lower limbs of insidious onset since 20 days (SUBACUTE), which began 2 years ago in the proximal region and gradually progressed to the distal region.
- Difficulty in squatting and getting up from squatting position and climbing stairs (PROXIMAL LOWER LIMB INVOLVEMENT)
- Difficulty in wearing and holding chappal (DISTAL LOWER LIMB INVOLVEMENT)
- No difficulty in combing hair, weight lifting (NO PROXIMAL UPPER LIMB INVOLVEMENT)
- No difficulty in eating, writing , shaving (NO DISTAL UPPER LIMB INVOLEMENT)
- Slight edema of the lower limbs which is of non-pitting type ( CARDIOMYOPATHY)
- No symptoms of sensory involvement (GANGLIONOPATHY AND PERIPHERAL NEUROPATHY ARE RULED OUT)
- No history of Pain along the nerve root (RADICULOPATHY ALONG SPINAL NERVE ROOT AND PLEXOPATHY ARE RULED OUT)
- No history of Fatiguability, Pharyngeal muscle problems (NMJ LESIONS ARE RULED OUT)
Other significant findings on examination are:
- On Examination of the Nervous system,
Higher mental functions, Sensory system and Cranial nerve functions are normal.
Motor system:
Tone - normal
Power - 4/5 in both the limbs i.e movement against moderate resistance.
Reflexes - absent in both the lower limbs.
(LOWER MOTOR NEURON LESION)
Inspection - Normal- On Examination of the Cardiovascular system,
Palpation-
- Apex heart beat felt downwards and outwards the 5th left intercostal space (DILATED CARDIOMYOPATHY)
- Palpable lift felt
- Palpable thrill in the neck (HYPERDYNAMIC CIRCULATION)
Auscultation-
- S1 and S2 are heard
- S3 is added
- Wide fixed split appears to be heard
(Edit : Wide Split S2 appears to be heard NOT a Fixed Split S2) - Kindly refer to the comments section of the blog for a more detailed discussion about this.
CAUSES OF THE PROBLEMS :
- Anatomical location of the root cause -
It appears to be an LMN Lesion (as discussed above - Hyporeflexia,Flaccidity, No upper limb involvement, etc)
- Anterior Horn Cell - Ruled out (Not assymetrical, no wasting, no fasciculations)
- Dorsal Root Ganglion - Ruled out (No sensory involvement)
- Spinal Nerve Root - Ruled out (No root pain along distribution of nerve)
- Plexus - Ruled out
- Peripheral nerve - Ruled out (No sensory involvement and no distal to proximal evolution hence Pure Motor Neuropathy, although rare, is also ruled out)
- Neuromuscular Junction - Ruled out (No fatigability, pharyngeal muscle problems)
- Muscle - It appears to be a muscle problem a.k.a MYOPATHY
- It is purely motor weakness
- Completely symmetrical
- Proximal > Distal, predominantly lower limb
- No sensory loss
- ANS is normal
- Physiological functional disability -
Types of Myopathy:
- Intermittent weakness - Ruled out (No previous history of similar weakness)
- Myoglobinuria -> Rhabdomyolysis
- No Myoglobinuria ->Channelopathies, Myasthenia Gravis
- Persistent weakness
- Inherited - It appears to be an Inherited defect.
- Acquired ->
- Inflammatory - Ruled out (No muscle pain or stiffness. No cutaneous manifestations as seen in Polymyositis, Dermatomyositis)
- Endocrine - Ruled out (Thyroid Function tests are normal which rules out Hoffman syndrome in Hypothyroidism and Hyperthyroidism Induced Myopathy)
- Mitochondrial - Ruled out (Red Ragged Fibers absent on Muscle Biopsy)
- Drugs - Ruled out (No intake of drugs causing myopathies like Glucocorticoids)
Inherited Myopathies and Muscular Dystrophies:
DIFFERENTIAL DIAGNOSES -
- Becker's Muscular Dystrophy - MOST LIKELY
- Duchenne Muscular Dystrophy (DMD) Age of onset is between 3 - 5 years
- Limb Girdle Muscular Dystrophy
- Emery Dreifuss syndrome
- Myotonic Dystrophy
- Biochemical abnormalities that could be a root cause at a molecular level -
An increased CK level should lead us to suspect a Dystrophinopathy.
DIAGNOSIS OF A DYSTROPHINOPATHY
- Molecular genetic testing can confirm a diagnosis of a dystrophinopathy and performing a muscle biopsy will not be required.
- Identification of a disease-causing mutation of the DMD gene establishes the diagnosis.
Techniques - The following methods are available for the molecular genetic analysis of the DMD gene
●Analysis for deletions/duplications using Multiplex ligation-dependent probe amplification (MLPA), Multiplex PCR, Florescence in situ hybridization (FISH), Long-range PCR, Chromosomal microarray (CMA).
●Mutation scanning and sequence analysis to detect point mutations
- Muscle biopsy was once important for the diagnosis of DMD and related disorders but is seldom needed now, since almost all patients are diagnosed with genetic testing.
- A Western blot assay of dystrophin can be used to predict the severity of the disease.
- Electromyography reveals myopathic changes consisting of small polyphasic potentials. However, it is never used in the diagnosis of DMD and BMD.
Basil T. Darras, (2020). Duchenne and Becker Muscular Dystrophy: Clinical features and diagnosis. In J.F.Dashe (Ed), UpToDate. Retrieved April 2020 from, https://www.uptodate.com/contents/duchenne-and-becker-muscular-dystrophy-clinical-features-and-diagnosis
- Pathology that could reflect the root cause at a cellular level -
BECKER'S MUSCULAR DYSTROPHY
- It is an X- Linked Recessive Disorder.
- Due to Dystrophin gene mutation
- Variable disease onset (5 -60 years)
- No mental retardation
- No contractures
- Cardiomyopathy is commonly seen.
TREATMENT PLAN :
Here are some solutions to tackle these root causes from upstream (soil from which the roots begin) or downstream (to treating the stem and branches aka palliation) in terms of pharmacological and non pharmacological, both in historical terms (past dominant treatments for the same cause and it's current evolution) as well as recent advances (ongoing trials and innovative approaches) :
1) Solution to tackle the Upstream -
EUGENICS in Muscular Dystrophy
- Patient: Diagnosed cases of DMD
- Indicator: Genetic Counseling, Promotion of Euthanasia
- Comparision: The first group comprises the older patients concerning their progressive respiratory insufficiency, whilst systematically requesting adapted ventilation assistance. The second group comprises second generation patients, who benefited from procedures, but for whom the completeness of treatment was not achieved.
- Outcome: "Concerning muscular dystrophy, confusion is inevitable, both in the social incidence, in doubtful intentions, and in a conditioning of consent, despite numerous protections which have already been proposed (genetic counseling, ethical committees, subsequent legislations ). If an urgent Legislation has to intervene, it will not be that claimed now concerning euthanasia, but that allowing the numerous contradictions harming or damaging the priority fight against illness to be clarified."
- Time/ Duration of study : 21.77 years (approximately)
- Type of study : Observational open label study
Y.Rideau & F. Rideau, (2007). Muscular Dystrophy, incurability, eugenics.
2) Solutions to tackle the Downstream (Palliative treatment)
Pharmacological Treatment -
- Glucocorticoids - In DMD, Prednisone and Deflazacort have been proved to be beneficial for improving motor function, strength, delaying the loss of ambulation reducing the risk of scoliosis, and improvement of Pulmonary function.
Prednisone is dosed at 0.75 mg/kg per day for the treatment of DMD.
Deflazacort is dosed at 0.9 mg/kg per day.
Novel Therapies-
- Eteplirsen
- Golodirsen
- Ataluren
- Gene therapy
- Creatine monohydrate
- Myostatin inactivation
- Cell therapy
- Idebenone
Basil T. Darras, (2020). Duchenne and Becker Muscular Dystrophy: Glucocorticoid and disease-modifying treatment. In J.F.Dashe (Ed), UpToDate. Retrieved April 2020 from,
Non-Pharmacological Treatment -
Rehabilitation:
- Long-leg braces for maintaining standing and/or walking
- Power stand-up motorized wheelchairs provide standing mobility
Health maintainance:
- Nutrition - Obesity and Malnutrition should be controlled by promoting a healthy diet with adequate calories, micronutrients, protein and fluid, especially Calcium and Vitamin D.
- Mental health - Routine assessment of the mental health of the patient and family at every clinic visit and referrals to a psychiatrist or psychologist if required
- Educational and vocational support
Basil T. Darras, (2018). Duchenne and Becker Muscular Dystrophy: Management and prognosis. In J.F.Dashe (Ed), UpToDate. Retrieved April 2020 from,
"Duchenne and Becker muscular dystrophy: Management and prognosis"
https://www.uptodate.com/contents/duchenne-and-becker-muscular-dystrophy-management-and-prognosis
Additional References:
Additional References:
- Harrison's Principles of Internal Medicine, 18e. New York, NY: McGraw-Hill; 2012.
- Marrow Videos and Lecture Notes, E.4. Bengaluru: Neuroglia Health Pvt. Ltd; 2020.
[5/27, 11:12 AM] UG Student 1:
ReplyDeleteWhy are thinking patient having wide fixed heart sound??
[5/27, 11:13 AM] UG Student 2: Very good question
[5/27, 11:13 AM] UG Student 2: So, Paradigm dictates that most patients with Becker's muscular dystrophy have some form of cardiac involvement (cardiomyopathy) and some conduction abnormalities such as incomplete or complete RBBB
[5/27, 11:13 AM] UG Student 2: Here is some evidence a study showing the prevalence of RBBB in patients with Becker's Dystrophy:
P - 19 cases (age range 16–41 years) with Becker muscular dystrophy
I - To investigate the prevalence, age distribution, and spectrum of cardiac involvement in a cohort of patients with Becker muscular dystrophy.
C - 22 healthy controls (age range 22–36 years).
O - The prevalence of Intraventricular conduction delay or right bundle branch block was present in 8 (42%) out of 19 patients.
Study design : Prospective non-invasive study with clinical, electrocardiographic, and echocardiographic assessment.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1025076/
[5/27, 11:13 AM] UG Student 2: So, Persistent (widened) splitting occurs when both A2 and P2 are audible during the entire respiratory cycle.
Any condition that causes a nonfixed delay in the closure of the pulmonic valve, or early closure of the aortic valve, will result in a wide split S2. Therefore, a persistent split S2 would occur in the setting of a right bundle branch block, pulmonary hypertension (RULED OUT) or pulmonic stenosis (delayed P2) (RULED OUT) or severe mitral regurgitation/ventricular septal defect (early A2 closure)(RULED OUT).
A RBBB causes a delay in the closure of the pulmonic valve, and thus a delay in P2, without any effect on A2.
https://www.healio.com/cardiology/learn-the-heart/cardiology-review/topic-reviews/second-heart-sound-s2
[5/27, 11:13 AM] UG Student 1: U r telling it was a pathological split
[5/27, 11:14 AM] UG Student 1: How do u confirm whether it is
[5/27, 11:14 AM] UG Student 1: Mobile or non mobile split
[5/27, 11:14 AM] UG Student 1: During inspiration VR increases and vice versa during expiration
[5/27, 11:15 AM] UG Student 2: Confirmation of a split is not possible as it varies depending on who is listening to the split. The only way to do it, is to listen carefully while the patient is inspiring and expiring.
[5/27, 11:15 AM] UG Student 2: So like I mentioned above,
In a Wide split, splitting of S2 is greater with inspiration and is less prominent with expiration. Whereas, in a Fixed split, S2 occurs when there is always a delay in the closure of the pulmonic valve, and there is no further delay with inspiration. Hence, there is not much variation with inspiration or expiration. The split remains the same.
[5/27, 11:15 AM] UG Student 2: If you want to know the underlying pathology, to confirm why the split is occurring i.e. To know whether it's a RBBB, the best way to confirm your diagnosis is by performing a ECG and Echocardiography.
[5/27, 11:17 AM] UG Student 1: Yeah I'm getting u what you are trying to say
[5/27, 11:18 AM] UG Student 1: But I am asking that...In Rbbb there is delayed P2 and on further inspiration there is more VR and takes more time to fill the ventricle and thus taking more time to close the valve thus accentuating the delay???
[5/27, 11:20 AM] UG Student 2: Yes absolutely.
[5/27, 11:21 AM] UG Student 1: So in that case...how can it be called fixed split?
[5/27, 11:22 AM] UG Student 2: Yeah, I need to correct it in my blog. It would be called a Persistent Widened Split and not a Fixed Split.
It is a Wide Split S2.
Delete"Typical EKG changes in BMD include an R:S ratio ≥ 1 in lead V1, tall R waves in the right precordial leads, deep Q waves in the inferolateral leads, short PR, and longer QTc interval. There are also conduction abnormalities including incomplete and complete right bundle branch block, incomplete and complete left bundle branch block, and infra-hisian block"
ReplyDeletehttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919702/#!po=0.925926